|
Real-time Estimate
Cboe BZX
01:17:26 10/02/2026 am IST
|
5-day change
|
1st Jan Change
|
|
1.395 USD
|
+4.89%
|
|
-2.10%
|
+3.70%
|
|
06/25/06 |
Chardan Capital Adjusts Ocugen Price Target to $7 From $6, Maintains Buy Rating
|
MT
| |
22/24/22 |
Chardan Adjusts Price Target on Ocugen to $5 From $4, Maintains Buy Rating
|
MT
| |
22/24/22 |
Chardan Raises Price Target on Ocugen to $5 From $4, Keeps Buy Rating
|
MT
| |
24/24/24 |
HC Wainwright Adjusts Price Target on Ocugen to $7 From $5, Maintains Buy Rating
|
MT
| |
31/23/31 |
Cantor Fitzgerald Adjusts Ocugen's Price Target to $2 From $2.50, Keeps Overweight Rating
|
MT
| |
08/23/08 |
Chardan Research Raises Ocugen's Price Target to $4 From $3.50, Buy Rating Kept
|
MT
| |
01/23/01 |
Chardan Upgrades Ocugen to Buy From Neutral, Citing Recent Sell-Off
|
MT
| |
01/23/01 |
Mizuho Adjusts Price Target on Ocugen to $3 From $5, Maintains Buy Rating
|
MT
| |
23/22/23 |
Mizuho Securities Starts Ocugen at Buy With $5 Price Target
|
MT
| |
15/22/15 |
HC Wainwright Adjusts Ocugen's Price Target to $6 from $7, Maintains Buy Rating
|
MT
| |
15/22/15 |
Roth Capital Reinstates Ocugen at Buy with $8 Price Target
|
MT
| |
02/22/02 |
Cantor Fitzgerald Starts Ocugen at Overweight With $4.50 Price Target
|
MT
| |
09/22/09 |
Chardan Trims Ocugen's Price Targe to $3.50 From $4, Maintains Neutral Rating
|
MT
| |
09/22/09 |
Chardan Research Adjusts Ocugen's Price Target to $3.50 From $4, Maintains Neutral Rating
|
MT
| |
28/22/28 |
HC Wainwright Adjusts Ocugen's Price Target to $8 from $10, Maintains Buy Rating
|
MT
| |
14/21/14 |
Analyst recommendations: Alliant Energy, Ally Financial, Alphabet, HSBC, Honest...
|  | |
11/21/11 |
OCUGEN : Chardan Adjusts Ocugen PT to $4.50 From $8, Maintains Neutral Rating
|
MT
| |
11/21/11 |
OCUGEN : Cantor Fitzgerald Adjusts Ocugen PT to $4 From $11, Maintains Neutral Rating
|
MT
| |
11/21/11 |
OCUGEN : HC Wainwright Adjusts Ocugen's Price Target to $10 From $12, Maintains Buy Rating
|
MT
| |
11/21/11 |
OCUGEN : Roth Capital Cuts Ocugen to Neutral From Buy, Price Target to $6 From $10
|
MT
| |
10/21/10 |
OCUGEN : Chardan Adjusts Price Target on Ocugen to $8 From $13, Maintains Neutral Rating
|
MT
| |
10/21/10 |
Today's analyst recommendations: Oracle, Facebook, Berkeley, Acushnet, Ocugen, London Stock Exchange, Flutter...
|  | |
07/21/07 |
OCUGEN : Cantor Fitzgerald Downgrades Ocugen to Neutral From Overweight, Adjusts PT to $11 From $15
|
MT
| |
03/21/03 |
OCUGEN : Cantor Fitzgerald Adjusts Ocugen PT to $15 From $4, Maintains Overweight Rating
|
MT
| |
09/21/09 |
OCUGEN : Chardan Capital Downgrades Ocugen to Neutral From Buy on Valuation, Adjusts Price Target to $13 From $0.70
|
MT
|
No results for this search Select your edition All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
|